Biodexa Pharmaceuticals (BDRX) Inventory (2015 - 2018)

Biodexa Pharmaceuticals (BDRX) has 4 years of Inventory data on file, last reported at $809376.6 in Q4 2018.

• For the quarter ending Q4 2018, Inventory fell 35.22% year-over-year to $809376.6; the trailing twelve-month figure through Dec 2018 stood at $809376.6 (down 35.22% YoY), and the FY2018 full-year result was $840066.8, down 30.7% from the prior year.
• Inventory retreated to $809376.6 in Q4 2018, from $1.4 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $1.4 million in Q2 2018 to a low of $696528.2 in Q4 2015.
• A 4-year average of $1.1 million and a median of $1.1 million in 2016 frame the typical range for Inventory.
• Across the five-year window, Inventory soared 45.83% in 2016 and plunged 35.22% in 2018, its largest moves.
• Tracing BDRX's Inventory over 4 years: stood at $696528.2 in 2015, then jumped by 45.83% to $1.0 million in 2016, then rose by 23.0% to $1.2 million in 2017, then sank by 35.22% to $809376.6 in 2018.
• Business Quant data shows BDRX's Inventory at $809376.6 in Q4 2018, $1.4 million in Q2 2018, and $1.2 million in Q4 2017.